Cooperating with pharmaceutical drone delivery demonstration experiment in Etajima City, Hiroshima Prefecture

PRODRONE Co., Ltd. (hereinafter referred to as PRODRONE) jointly conducted a pharmaceutical drone delivery demonstration experiment (this experiment) with Qol Holdings Co., Ltd. (hereinafter referred to as Qol) and Kamomeya Co., Ltd. (Kamomeya) in Etajima City, Hiroshima Prefecture for two days, February 21st (Monday) and 22nd (Tuesday), 2022. In this experiment, we used a prescription to dispense medication to an actual patient, and then used a drone to deliver the actual medication. The aim is to deliver the entire process from a patient receiving an online medical consultation, to a prescription being issued, to having the medicine delivered to their doorstep. In this experiment, PRODRONE's "PD6B Type 3" automatically navigated an 8km flight route under strong winds. Comments from Shunsuke Toya, President and Representative Director of Prodrone Co., Ltd.

“If drone delivery of medicines between remote islands, mountainous areas, or during disasters can be implemented, it will greatly contribute to the enhancement of medical care in areas with insufficient access to medical care.The route used for this demonstration is at risk of roads being blocked in the event of a disaster.Drugs during normal times In addition to being used for delivery, the range of uses of drones will expand if they can be used in times of disaster.We continue to develop and test our aircraft on a daily basis to ensure that they can fly safely and securely, and we will continue to provide drones that solve social issues and provide new value.

■Status of the demonstration experiment on the day

■Route map